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Brevetoxin derivatives that inhibit toxin activity
Sherry L Purkerson-Parker1, Lynne A Fieber2, Kathleen S Rein3,
Tchao Podona3 and Daniel G Baden4
Background: The brevetoxins are marine neurotoxins that interfere with the
normal functions of the voltage-gated Na+ channel. We have identified two
brevetoxin derivatives that do not exhibit pharmacological properties typical of
the brevetoxins and that function as brevetoxin antagonists.
Results: PbTx-3 and benzoyl-PbTx-3 elicited Na+ channel openings during
steady-state depolarizations; however, two PbTx-3 derivatives retained their
ability to bind to the receptor, but did not elicit Na+ channel openings.
α-Naphthoyl-PbTx-3 acted as a PbTx-3 antagonist but did not affect Na+
channels that were not exposed to PbTx-3. β-Naphthoyl-PbTx-3 reduced
openings of Na+ channels that were not exposed to PbTx-3.
Conclusions: Some modifications to the brevetoxin molecule do not alter either
the binding properties or the activity of these toxins. Larger modifications to the
K-ring sidechain do not interfere with binding but have profound effects on their
pharmacological properties. This implies a critical function for the K-ring
sidechain of the native toxin.
Introduction
The brevetoxins are a series of structurally related neuro-
toxins produced by the ‘red tide’ dinoflagellate Gymno-
dinium breve [1]. Two skeletal types are known, each type
having a number of congeners that vary in the K-ring (type
B) or J-ring (type A) sidechains (Figure 1). These toxins are
responsible for massive fish kills and marine mammal mor-
talities [2,3], primarily on Florida’s Gulf Coast. Consump-
tion of toxin-tainted shellfish induces a syndrome in
humans known as neurotoxic shellfish poisoning. Symp-
toms include nausea, vomiting, diarrhea, bronchoconstric-
tion, reversal of temperature sensation and parasthesias [4].
These effects are apparently brought about by the inter-
action of the toxins with a receptor site (site 5) on the
voltage-gated Na+ channel [1]. Specific activities include:
a shift of activation potential for Na+ channel opening to
more negative values (i.e., channels open at normal
resting potentials) [5,6]; inhibition of inactivation [5,6];
increased mean channel open times [5]; and induction of
sub-conductance states [5,7]. Together these effects
result in a dose-dependent depolarization of excitable
membranes [8–10]. 
The functional α subunit of the voltage-gated Na+
channel is composed of four highly homologous domains.
Each domain includes six transmembrane α helices
(S1–S6). The highly charged S4 α helices are thought to
comprise the voltage-sensing functionality of the channel
[11]. Photoaffinity labeling of the Na+ channel has indi-
cated that the specific brevetoxin-binding site, at least for
the K-ring sidechain, is located near the S5–S6 extracellu-
lar loop of domain 4 [12]. The toxin is believed to orient
itself across the membrane, parallel to the lipid bilayer
and the α helices, with the K-ring sidechain end of the
molecule pointing outward [13].
The evaluation of the binding properties of several natural
and semisynthetic toxins, correlated with computer molecu-
lar modeling, has led to a ‘common pharmacophore’ hypoth-
esis for site-5 ligands of the voltage-gated Na+ channel.
Briefly, it appears that both a critical length [14] and a spe-
cific conformation (relatively straight) [15,16] are required
for toxin binding. The interactions between the toxin and
its receptor site are believed to be mostly hydrophobic;
however, the A-ring lactone provides enhanced stability to
the ligand–receptor complex, presumably by acting as a
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hydrogen-bond acceptor [17]. Interestingly, specific regions
of the toxin molecule can be correlated with the four activi-
ties listed above. The relatively rigid H–K-ring region
appears to possess characteristics of a requisite ligand-
binding region, and the A-ring lactone is critical for inducing
longer mean open times. The overall length of the toxin
appears to deliver the lactone to an activity locus on the
channel responsible for inhibition of inactivation; this is
exemplified by the lack of this effect in a truncated form of
brevetoxin possessing the binding H–K region and intact
A-ring, but possessing a shorter spacer region (through dele-
tion of rings B–E) [18].
As part of a continuing effort to develop and refine the
common pharmacophore hypothesis, we evaluated three
new brevetoxin derivatives (Figure 2) in electrophysiolog-
ical experiments. Our study builds on recent experiments
[6] that examined the effects of PbTx-3 on single Na+
channels in detail. Recordings from channels in individual
membrane patches were made before and after toxin
application. An advantage of this approach is that chan-
nels in an individual patch serve as their own control,
thereby taking into account normal variability in Na+
channel kinetics observed in membrane patches. Our
comprehensive observations have led to the surprising
conclusion that, although the three derivatives examined
bind to site 5, two of them do not elicit any of the typical
brevetoxin responses. Furthermore, at least one of these
derivatives inhibits brevetoxin activity. In other words,
our efforts have identified the first brevetoxin antagonist. 
Results
The brevetoxin derivatives whose binding characteristics
and physiological actions on Na+ channels were evaluated
in this study were benzoyl-PbTx-3 (1), α-naphthoyl-
PbTx-3 (2) and β-naphthoyl-PbTx-3 (3; Figure 2). The
binding affinities of the three derivatives were assessed in
a competitive displacement assay (Figure 3). All three
derivatives were able to displace 3H-PbTx-3 from site 5
with nanomolar affinities. Thus, derivatization of the
K-ring sidechain does not significantly interfere with the
binding of the toxin to its receptor site. In fact, in two
cases (1 and 3) binding is enhanced over that of PbTx-3.
As a comparison, the site-1 toxin tetrodotoxin (TTX),
which does not competitively displace site-5 toxins, was
studied for its potential blocking actions of PbTx-3 in
physiological assays.
Most subtypes of voltage-activated Na+ channels open
briefly and with a short latency in response to depolariza-
tions within the Na+ channel activation range from hyper-
polarized holding potentials at which they are closed but
not inactivated (‘step depolarizations’). Furthermore, Na+
channels inactivate during prolonged depolarizations
without a return to a hyperpolarized potential and thus
are normally not open during prolonged, steady-state
depolarizations. In these experiments with B50 cells, the
presence of normal Na+ channel activity was confirmed
by step-depolarization tests. In addition, a normal
absence of channel activity was noted during steady-state
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Figure 1
Structure of the two brevetoxin skeletal types and several congeners.
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Figure 2
Structure of the brevetoxin derivatives evaluated in this study.
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depolarizations lasting 7.2 s of continuous observation.
Consistent with previous studies using nodose ganglion
[5] and B50 and B104 cell lines [6], the most notable
effect of PbTx-3 was its ability to open Na+ channels in
B50 membrane patches during steady-state depolariza-
tions lasting many seconds.
Unitary Na+ currents in the steady state are illustrated in
Figure 4. The presence of Na+ channels in the membrane
patches was confirmed during step-depolarization trials
performed before the steady-state experiment of
Figure 4a and b, and no Na+ channel openings were
observed during steady-state depolarizations in the
absence of toxin (Figure 4a; control). PbTx-3 application
to the bath elicited Na+ channel openings to the full open
amplitude (Figure 4b) and also to substates [5] during
steady-state depolarizations (see first trace of Figure 4b).
Figure 4 also demonstrates the effects of prior exposure to
TTX on PbTx-3-elicited steady-state Na+ channel open-
ings. TTX was added to the bath before the membrane
seal was formed (Figure 4c), and then PbTx-3 was added
(Figure 4d). No PbTx-3-induced channel openings were
observed in the presence of TTX (n = 5) during periods
ranging from 7.2 to 9 s of continuous observation. Thus,
although TTX and PbTx-3 act at different sites on the
Na+ channel molecule, TTX blocks PbTx-3-induced
effects on steady-state channel openings. 
In an effort to refine our common pharmacophore hypoth-
esis and to correlate structural features with physiological
consequences, we examined the effects of PbTx-3 deriva-
tives on Na+ channels. Figure 5 illustrates unitary Na+ cur-
rents in the steady state in the presence of PbTx-3 or one
of three derivatives of PbTx-3. During step depolariza-
tions these membrane patches were observed to contain
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Figure 3
Competitive displacement assays for brevetoxin derivatives 1, 2 and 3,
and PbTx-3.
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Figure 4
Steady-state Na+ channel currents in two
different membrane patches recorded at a
continuous voltage equal to the command
potential of —50 mV (top) or –10 mV (bottom)
plus the cell’s unknown resting potential. The
Na+ current activation voltage observed in
whole-cell current–voltage experiments [6]
estimates the cell resting potentials in this and
subsequent experiments in normal
extracellular solution (ECS; see the Materials
and methods section) at –20 to –10 mV.
Traces illustrate a membrane patch (a) before
and (b) after exposure to PbTx-3 (100 nM,
20 KHz sampling rate, n = 50) or a membrane
patch exposed first (c) to 100 nM TTX and
then (d) to 100 nM PbTx-3 (100 nM, 50 kHz,
n = 5). No channel openings were observed in
TTX at command potentials between –50 and
–10 mV. Although it was not possible to
determine that the membrane patches of
TTX-exposed cells contained Na+ channels,
we estimate that the probability that these five
membrane patches lacked Na+ channels is
very low because under our culture conditions
only 2% of membrane patches from B50 cells
lack functional Na+ channels.
Control
–50 mV
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–50 mV
TTX
–10 mV
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–10 mV
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normally behaving Na+ channels, and no Na+ channel
openings were observed during steady-state depolariza-
tions in the absence of toxin (Figure 5a; control). PbTx-3
application to the bath elicited substate and full open
amplitude Na+ channel openings (second and third traces
of Figure 5b, respectively). In separate membrane
patches, following control observations, the PbTx-3 deriv-
ative benzoyl-PbTx-3 elicited Na+ channel openings in
the steady state (Figure 5c), but α-naphthoyl-PbTx-3 and
β-naphthoyl-PbTx-3 did not (Figure 5d and e). Whereas
some modifications (such as benzoyl) of the PbTx-3 mol-
ecule do not result in loss of effectiveness in eliciting
steady-state openings [6], the larger naphthoyl groups
appear to abolish the ability of the toxin molecule to elicit
steady-state openings. This raises the question of whether
the larger naphthoyl groups are blocking the channel.
We studied the effects of α- and β-naphthoyl-PbTx-3 on
Na+ channel openings during successive depolarizations
lasting 50 ms to –10 or –20 mV from a resting command
potential of –100 mV in order to test the ability of these
derivatives to block unmodified (control) Na+ channels.
During depolarizing pulse experiments, α-naphthoyl-
PbTx-3 did not block Na+ channels (n = 10) and did not
induce a shift in the threshold for channel opening (n = 3;
data not shown). The actions of β-naphthoyl-PbTx-3
during 50 ms step depolarizations to –10 mV are summa-
rized in Figure 6. Figure 6a and b represents recordings
before and after β-naphthoyl-PbTx-3 treatment, respec-
tively. Figure 6c and d are the ensemble averages of 24
50 ms depolarizations under these conditions. In the
control period, most Na+ channel openings occurred
during the first 5 ms of the depolarizing pulse but later
openings were occasionally observed. After the addition
of 100 nM β-naphthoyl-PbTx-3 to the bath, fewer Na+
channel openings occurred, and few openings occurred
later than 5 ms after the beginning of the pulse, which is
unlike the late channel-opening pattern that is character-
istic of PbTx-3 [6]. These results suggest that channel
activation and re-opening were inhibited by β-naphthoyl-
PbTx-3. The time course of macroscopic inactivation of
the ensemble-averaged currents (τh) was fit by a single
exponential, and the areas under the fitted curves were
calculated. The area was 11.1 pA × ms before toxin appli-
cation (Figure 6c) and 1.29 pA × ms after toxin application
(Figure 6d), a decrease of 88% in this experiment. In
ensemble averages from six patches consisting of depolar-
izations to –10 or –20 mV, the mean area of the controls
was 32.68 ± 18.2 pA × ms and that after toxin exposure
was 9.23 ± 6.88 pA × ms, an average of 71.8% less after
exposure to β-naphthoyl-PbTx-3. Control area averages
were significantly different from β-naphthoyl-PbTx-3-
exposed area averages in the same membrane patches
(paired t-test, p ≤ 0.008). 
An additional feature of the actions of β-naphthoyl-PbTx-3
during brief depolarizations was that it induced a  greater
than 5 mV hyperpolarizing shift in the activation threshold
(in 2 out of 2 patches; data not shown). This shift is an
independent consequence of the apparent inhibitory effect
of this derivative on Na+ channel openings. 
The potential for α- and β-naphthoyl-PbTx-3 to act as
PbTx-3 antagonists is suggested by three results: the
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Figure 5
Steady-state currents in four different
membrane patches at a steady-state command
voltage of –50 mV. (a) Control traces
preceded the test with PbTx-3, and are
representative of control recordings observed
in all four patches during 7.2 s of continuous
observation. Membrane patches were exposed
to (b) PbTx-3 (100 nM, n = 50) or (c,d,e) 1 of
3 derivatives of PbTx-3 (benzoyl-PbTx-3, n = 3,
α-naphthoyl-PbTx-3, n = 8; or β-naphthoyl-
PbTx-3, n = 6, respectively; all 100 nM). The
experimental recordings are representative of
7.2 s of continuous observation in PbTx-3 or
the indicated derivative.
PbTx-3
–50 mV
Benzoyl-PbTx-3
–50 mV
a -Naphthoyl-PbTx-3
–10 mV
b -Naphthoyl-PbTx-3
–10 mV
(b)
Control
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apparent ability of α- and β-naphthoyl-PbTx-3 to dis-
place the native toxin from its binding site; the lack of
steady-state channel activity in the presence of α- and
β-naphthoyl-PbTx-3; and the inhibition of Na+ channels
by β-naphthoyl-PbTx-3. To test the possible PbTx-3
antagonist effects of α-naphthoyl-PbTx-3, we investi-
gated the interactions between PbTx-3 or benzoyl-
PbTx-3 and α-naphthoyl-PbTx-3. Figure 7 shows the
steady-state effects of addition of α-naphthoyl-PbTx-3
to the bath several minutes after addition of PbTx-3 to
the bath. α-Naphthoyl-PbTx-3 abolished Na+ channel
activity induced in the steady state by PbTx-3
(Figure 7b,c). Figure 8 shows that some blocking effects
of α-naphthoyl-PbTx-3 extend to benzoyl-PbTx-3,
which has the highest binding affinity of the group.
Benzoyl-PbTx-3 was added to the bath after control
records were made (Figure 8a,b), and the cell was addi-
tionally exposed to α-naphthoyl-PbTx-3 (Figure 8c).
Benzoyl-PbTx-3-induced channel openings were
blocked by further addition of α-naphthoyl-PbTx-3 to
the bath, although occasional, brief Na+ channel open-
ings were observed (third trace of Figure 8c). In the
membrane patch shown, Na+ channels were open for
12.8 ms of each second of observation time in benzoyl-
PbTx-3, whereas after addition of α-naphthoyl-PbTx-3
channels were open for 0.37 ms of each second.
The lack of any demonstrable physiological effect elicited
by α-naphthoyl-PbTx-3 prompted us to evaluate the toxi-
city of this derivative in a fish bioassay. The concentration
required to kill 50% of the fish (LC50) for this compound
was determined to be 142 nM in a 24 h assay. This is in
contrast to an LC50 of 15 nM for PbTx-3. 
Discussion
The pharmacological interactions between TTX and
PbTx-3 illustrate a unique comparison of the competition
between site-1 and site-5 Na+ channel toxins. Although
TTX and PbTx-3 act at different sites on the Na+ channel
molecule, the effects of TTX preclude those of PbTx-3
regardless of the order in which these toxins are added to
membrane patches. Thus, if TTX is applied first to mem-
brane patches containing Na+ channels, it blocks PbTx-3-
induced effects on steady-state channel openings.
Conversely, if PbTx-3 is applied first, eliciting steady-
state Na+ channel openings, subsequent application of
TTX blocks them [6]. Therefore, TTX-induced channel
block at site 1 takes precedence physiologically, regardless
of ‘competing’ PbTx-3-induced modulation of channel
opening occurring at site 5. 
Table 1 summarizes the results of the PbTx-3 binding
and single-channel experiments. All three PbTx-3 deriva-
tives bind site 5 of the voltage-gated Na+ channel and
have physiological activities with some relationship to
native PbTx-3. Benzoyl-PbTx-3 is similar to native PbTx-
3 in its ability to elicit Na+ channel openings in the steady
state. These openings, like those elicited by native PbTx-
3, lasted tens of milliseconds, and occurred more fre-
quently after the first 5 ms of depolarization, suggesting
that channel inactivation had been slowed. Although a full
characterization of the effects of benzoyl-PbTx-3 was not
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Figure 6
Single Na+ channel currents during
successive command depolarizations to
–10 mV from a command potential of
–100 mV in the same membrane patch
(a) before and (b) after exposure to
β-naphthoyl-PbTx-3 (100 nM, n = 6).
(c,d) Ensemble averages indicated a
reduction in peak Na+ current. The average
area under the β-naphthoyl-PbTx-3 curve was
71.8 ± 18.3% less than that of the control.
b -Naphthoyl-PbTx-3
(d)
Control
(c)
b -Naphthoyl-PbTx-3
(b)
Control
(a)
1 pA
5 ms
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–10 mV
–100
made, it appears that the relatively small modification of
the PbTx-3 sidechain made in the benzoyl derivative
does not modify the actions of the PbTx-3 molecule to
any significant extent. 
In contrast to benzoyl-PbTx-3, α-naphthoyl-PbTx-3 and
β-naphthoyl-PbTx-3 did not open Na+ channels in the
steady state when applied alone (Figure 4). Thus, modifi-
cation of the PbTx-3 sidechain with large naphthoyl groups
abolished the most characteristic physiological activity of
PbTx-3, despite binding constants that indicate these mod-
ifications do not interfere with the derivatives’ binding to
the appropriate site on the Na+ channel molecule. 
β-Naphthoyl-PbTx-3 inhibited Na+ channel openings in
test depolarization experiments, whereas α-naphthoyl-
PbTx-3 blocked PbTx-3- and benzoyl-PbTx-3-induced
Na+ channel activity in steady-state experiments. Thus,
large modifications of the PbTx-3 sidechain markedly
changed the physiological effects of PbTx-3 from
enhancement of Na+ channel openings [5,6] to both block
of unmodified Na+ channels (β-naphthoyl-PbTx-3) and
block of Na+ channels activated by PbTx-3 or benzoyl-
PbTx-3 (α-naphthoyl-PbTx-3). The effectiveness of
α-naphthoyl-PbTx-3 as a PbTx-3 antagonist is interpreted
as an observable physiological consequence of the dis-
placement of PbTx-3 from its binding site by α-naph-
thoyl-PbTx-3. However, occasional, ‘brief’ Na+ channel
openings were observed (third trace of Figure 8c) when
benzoyl PbTx-3 is the activator. This residual activity may
be a consequence of the enhanced affinity of benzoyl-
PbTx-3 (Ki = 0.2 nM) over PbTx-3 (Ki = 3.0 nM) for site 5
of the Na+ channel. 
The physiological effects of β-naphthoyl-PbTx-3 are con-
siderably more complex than those of the α derivative. The
voltage dependence of Na+ channels means that channels
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Figure 7
Steady-state currents recorded in normal ECS at a continuous
command voltage of –50 mV (a) before and after exposure to (b) PbTx-
3 (100 nM) and then (c) α-naphthoyl-PbTx-3 (100 nM, n = 5). The
frequency of channel opening in the control was 0 ms/s; after PbTx-3,
12.8 ms/s; and after the addition of α-naphthoyl-PbTx-3, 0.02 ms/s.
a -Naphthoyl-PbTx-3
–50 mV
(c)
PbTx-3
–50 mV
(b)
Control
–50 mV
(a)
2 pA
10 msChemistry & Biology
Figure 8
Steady-state currents recorded in normal ECS at a continuous
command voltage of –50 mV (a) before and after exposure to
(b) benzoyl-PbTx-3 (100 nM) and then (c) α-naphthoyl-PbTx-3
(100 nM, n = 2). The frequency of channel opening in the control was
0 ms/s; after benzoyl-PbTx-3, 12.8 ms/s; and after the addition of
α-naphthoyl-PbTx-3, 0.37 ms/s.
a -Naphthoyl-PbTx-3
–50 mV
(c)
Benzoyl-PbTx-3
–50 mV
(b)
Control
–50 mV
(a)
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5 msChemistry & Biology
open only sporadically at voltages near the activation
threshold and that channel-opening activity is greater at
voltages more depolarized than this threshold. A shift in the
Na+ channel activation threshold toward more hyperpolar-
ized voltages, as observed upon exposure of membrane
patches to β-naphthoyl-PbTx-3, is an independent conse-
quence of the apparent inhibitory effect of this derivative
on Na+ channel openings. A hyperpolarizing shift alone
would increase channel activity at voltages near the peak of
the voltage-activation range. Instead, a significant decrease
in channel opening was observed in the presence of
β-naphthoyl-PbTx-3. Thus, β-naphthoyl-PbTx-3 exerts
two contradictory effects on channel gating:  lowering of
the threshold for activation, and apparent channel block. 
Although the mechanism of Na+ channel block by β-naph-
thoyl-PbTx-3 is unclear, the mode of action of the breve-
toxins is believed to be through the lipid border of the
channel and not from the pore surface [6]. This is in con-
trast to a site-1 blocker such as TTX which acts through
channel occlusion. 
One interpretation of these results is that PbTx-3 lowers
the activation threshold by lowering the activation barrier
to the conformational change that occurs when channels
shift from the closed to the open state. At the same time
PbTx-3 increases mean channel open times by stabilizing
the open conformation relative to the closed and inacti-
vated conformations. The β-naphthoyl derivative also
lowers the activation barrier between the closed and open
states, but it destabilizes the open state relative to the
closed or inactivated states, which results in apparent inhi-
bition of channel opening. The destabilizing actions of
β-naphthoyl-PbTx-3 may result in a decrease in the
channel open time, but this was not determined here. As a
result, the data presented for β-naphthoyl-PbTx-3 cannot
rule out channel occlusion. It is possible that the bulky
sidechain might penetrate the pore while the toxin is
strategically placed at site 5. 
Photoaffinity labeling of the brevetoxin binding site using
a p-azidobenzoyl-PbTx-3 derivative has indicated the the
p-azido group is located near the S5–S6 extracellular loop
on domain 4 of the voltage-dependent Na+ channel. That
a synthetic modification to the portion of the molecule
that interacts with this loop should abolish all activity is
intriguing and suggests that this portion of the α subunit
and the K-ring sidechain of brevetoxin have a critical func-
tion. This loop contains the α-scorpion toxin binding site
(part of site 3). Binding of toxin is strongly voltage depen-
dent, indicating that this site may be involved in channel
activation and inactivation [11]. An important role for the
K-ring sidechain in brevetoxin has previously been sug-
gested [19]. Conformational analysis of the sidechains of
native and derivative toxins reveals no obvious differences
in conformational preferences. The global minimum for
the native toxin places the sidechain methylene away
from the K-ring with the hydroxyl group positioned over
the ring by a hydrogen bond to the K-ring ether oxygen.
One might imagine that this orientation would be increas-
ingly difficult to achieve as steric bulk of the sidechain
increased. This appears not to be the case for any of the
derivatives 1, 2 or 3, however, as all three have very similar
global minima. Other conformations placing the sidechain
away from the toxin are equally accessible. Furthermore,
as binding is unaffected it seems unlikely that a conforma-
tional change is responsible for the observed electrophysi-
ological effects. It seems more likely that the brevetoxin
skeleton serves to anchor the toxin sidechain into the
proper position for a crucial interaction with a portion of
the α subunit (possibly the S5–S6 extracellular loop of
domain 4). Large groups such as α- and β-naphthoyl deriv-
atives may not interfere with binding but do disrupt this
interaction. This hypothesis could be tested by evaluating
a semisynthetic toxin that lacks a sidechain.
Although α-naphthoyl-PbTx-3 behaves as a brevetoxin
antagonist in vitro, in vivo it acts as a toxin with an LC50 of
142 nM. All other brevetoxin derivatives evaluated exhibit
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Table 1
Summary of effects of PbTx-3 and its derivatives.
PbTx-3 Benzoyl PbTx-3 α-Naphthoyl-PbTx-3 β-Naphthoyl-PbTx-3 
Ki (nM) 3.0 0.2 4.68 1.06
Promotes steady state 
Na+ channel openings Yes Yes No No
Block of unmodified Na+ channels No nd No Yes
Inhibits PbTx-3
or benzoyl PbTx-3-induced
steady-state openings — – Yes nd
Hyperpolarized shift in 
Na+ channel activation curve 6.7 mV* No No ~5 mV
*From [6]. nd, not determined.
a positive correlation between the inhibitor concentration
required to displace 50% of the specific binding of the
radiolabeled ligand (IC50; from the receptor binding assay)
and LC50. On the basis of the IC50, we could expect an
LC50 roughly equivalent to that of PbTx-3 (15 nm) [15].
We cannot rule out another mechanism of activity, but we
suspect that the toxicity was due either to the activity of
an esterase cleaving the α-naphthoyl derivative to PbTx-3
or metabolic conversion to another active metabolite. The
preparation of a structurally similar derivative with a less
labile linkage could provide an antagonist that acts both
in vitro and in vivo.
Significance
The brevetoxins are polyether ladder molecules pro-
duced by the ‘red tide’ dinoflagellate Gymnodinium breve
that induce a syndrome known as neurotoxic shellfish
poisoning when consumed in tainted shellfish. These and
other dinoflagellate-derived polyethers cause severe and
sometimes fatal neurological dysfunction after consump-
tion of contaminated seafood. Blooms of these toxin-pro-
ducing organisms can cause massive fish kills and
marine mammal mortalities. The production and distrib-
ution of dinoflagellate-derived polyethers can therefore
have severe and deleterious impacts on public health,
environmental resources and local economies. Polyether
ladder toxins are involved in ‘red tide’ and incidences of
shellfish poisonings worldwide and the frequency and
distribution of red tides appear to be increasing.
Efforts to counteract the deleterious effects of these potent
neurotoxins should begin with a precise understanding of
the molecular interactions required for toxicity. These
molecules interact with the voltage-gated Na+ channel,
altering the properties of excitable membranes. This study
expands on the ‘common pharmacophore’ hypothesis,
which strives to identify the salient molecular features
required for receptor binding and activity. This study has
revealed that small modifications to the K-ring sidechain
of the brevetoxin molecule have little effect on binding to
the receptor site or pharmacological activity; however,
bulky groups (α-naphthoyl and β-naphthoyl) do not
inhibit binding but have a profound influence on activity.
This suggests a crucial role for the K-ring sidechain in
eliciting pharmacological effects. A more thorough evalu-
ation of this crucial interaction could lead to a better
understanding of the mechanism of neurotoxicity. Not
only can these derivatives serve as a molecular probes but
their ability to act as antagonists suggests possible oppor-
tunities for the development of therapies for intoxicated
individuals.
Materials and methods
Dinoflagellate cultures
Unialgal cultures of Gymnodinium breve were grown in 10 l carboys in
Wilson’s NH15 media. The temperature was maintained at 20°C under
continuous illumination from Grow-Lux Wide Spectrum fluorescent
lamps at an incident illumination of 400 Lux. 
Toxin purification and characterization
Brevetoxins were purified from laboratory cultures by a combination of
chloroform/methanol extraction and thin-layer chromatography [1].
PbTx-3 was routinely purified by high performance liquid chromatogra-
phy (HPLC; 85% isocratic methanol) using a Microsorb-MV, C-18
column (5 µM, 25 cm bed) and monitored by UV at 215 nM. 1H-NMR
spectra were recorded in CDCl3 (CHCl3 internal standard) at 400
MHz. Mass spectra were run in either desorption chemical ionization
(DCI) or fast-atom bombardment (FAB) mode. High-resolution mass
spectra were obtained from the mass spectrometry facility at the Uni-
versity of California, Riverside. 
Synthesis of toxin derivatives
A tenfold excess (relative to PbTx-3) of carbonyl diimidazole and the cor-
responding acid (benzoic, α-naphthoic or β-naphthoic) were combined
under nitrogen, at room temperature, in dry benzene. The solution was
stirred for 30 min and then added to PbTx-3 in a 5 ml reaction vial. The
reaction vial was sealed and the mixture was stirred overnight at 80°C.
The reaction mixture was washed with an equal volume (3×) of saturated
sodium bicarbonate, an equal volume (3×) of 10% HCl and evaporated
under vacuum. The residue was purified using HPLC.
Benzoyl-PbTx-3 (1). Diagnostic peaks in the 1H NMR include δ7.44
(2H, t, J = 7.2 Hz), 7.56 (1H, t, J = 7.2 Hz), 8.061 (2H, d, J = 8.4 Hz),
4.81 (2H, dd, J = 5.2 Hz) (C42). The C42 methylene is typically shifted
downfield from its position in PbTx-3, and these diastereotopic protons
are split into a doublet of doublets in the esters, whereas they appear
as a singlet in PbTx-3. DCI MS (NH3): 1002 (M + 1). HRMS (FAB):
calc’d for C57H77O15 (MH+), calc’d 1001.5262, found 1001.5287.
α-Naphthoyl-PbTx-3 (2). Diagnostic peaks in the 1H NMR include
δ8.93 (1H, d, J = 8.8 Hz), 8.23 (1H, d, J = 8.8 Hz), 8.03 (1H, d,
J = 8.8 Hz), 7.83 (1H, d, J = 8.8 Hz), 7.64 (1H, t, J = 8.8 Hz), 7.44 (2H,
m), 4.92 (2H, dd, J = 5.2 Hz) DCI MS (NH3): 1052 (M + 1).
HRMS (FAB): calc’d for C61H79O15 (MH+), calc’d 1051.5419,
found 1051.5367.
β-Naphthoyl-PbTx-3 (3). Diagnostic peaks in the 1H NMR include
δ8.64 (1H, s), 7.95 (3H, m), 7.58 (3H, m) 4.89 (1H, s). 
Receptor-binding experiments
Synaptosomes were prepared by the method of Dodd et al. [20] from
the whole brains of male Sprague–Dawley rats. Total binding was mea-
sured using a  previously described rapid centrifugation technique
[15]. IC50 data were obtained by fitting a one-site competition curve to
displacement data using the program Prism (v 1.0, Graph Pad, Inc.).
Although a detailed analysis of binding parameters was not performed,
binding was assumed to be competitive by analogy with p-azidoben-
zoyl-PbTx-3 and other brevetoxin derivatives [12,15]. Inhibition con-
stants (Kis) were calculated by the method of Cheng and Prussoff [21]. 
Computational methods
Internal coordinate Monte Carlo sampling, minimization using the MM2*
force field and structure comparisons were performed using Macro-
Model (v. 6.5) and Batchmin (v. 6.5) [22]. Dihedral angles of the K-ring
sidechain were varied randomly within a range of 0 to ± 180°. Mini-
mizations were performed using the truncated Newton Raphson algo-
rithm with a maximum of 2000 iterations, a derivative convergence of
0.01 kJ/(Å-mol), and a large (50 kJ/mol) energetic window.
Cell culture
The B50 cell line, subcultured from an original culture provided by
D. Schubert (Salk Institute, San Diego, CA), was maintained as previ-
ously described [6]. The B50 cell line expresses types I and II Na+
channel mRNAs [23].
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Icthyotoxicity
Icthyotoxicity was assessed in a 24 h assay using mosquito fish, Gam-
busia affinis, as previously described [15].
Electrophysiological recording and analysis 
Single Na+ channel recordings were made using the cell-attached con-
figuration of the patch-clamp technique, using thick-walled borosilicate
pipettes (WPI, Inc., Sarasota, FL, USA) of 3–6 MΩ coated with Sylgard
(Dow Corning Corp., Midland, MI, USA) to reduce electrode capaci-
tance. Cell-attached single-channel recordings were made with an
Axopatch 1D and digitized by a Labmaster TL-1 converter (both from
Axon Instruments, Foster City, CA, USA) to a 486-33 MHz IBM-com-
patible computer using the PClamp6 Programs (Axon Instruments).
Recordings made at room temperature were digitized at 50 kHz unless
otherwise stated, and lowpass filtered at 2 kHz.
The bath solution (ECS) for single-channel recordings contained (in mM):
160 NaCl, 3 KCl, 1 CaCl2, 0.6 MgCl2, 7 D-glucose and 10 N-[2-hydrox-
yethyl]piperazine-N′-[2-ethanesulfonic acid]-(HEPES-)NaOH, pH 7.4.
The pipette solution consisted of ECS with additions of 30 mM Et4NCl,
2.5 mM BaCl2 and 10 µM CdCl2 (to block K+ and Ca2+ channels). 
Aqueous stock solutions of PbTx-3 and PbTx-3 derivatives were pre-
pared from concentrated solutions in 95% ethanol before addition to
test dishes. Toxin was applied to cells by pipetting several microlitres of
toxin in a bolus dose into the edge of the bath far from the cell under
study. The final concentration of ethanol was 0.01%.
Assessment of the actions of PbTx-3 or its derivatives on single Na+
channels was made using a recently described protocol [6]. Channel
activity was recorded first in the absence of toxin (control). PbTx-3 or
one of its derivatives was applied to the bath surrounding each mem-
brane patch. Because of the lipophilic nature of PbTx-3, the toxin
reached Na+ channels in the membrane patch by lateral diffusion
in the cell membrane. Channel activity was recorded 30 s after toxin
application. Tetrodotoxin solutions (TTX, Research Biochemicals
International, Natick, MA, USA) were prepared fresh daily. Unless
otherwise mentioned, reagents were purchased from Sigma
(St. Louis, MO, USA).
Single-channel records were analyzed as previously described [6]
using the PClamp6 programs. The voltages associated with single-
channel data represent the negative of the voltage applied to the mem-
brane patch by the amplifier, referred to as the command potential.
These voltages represent hyperpolarizations of the patch membrane
[24]. It must be noted, however, that the actual patch potential equals
the sum of the command potential and an unknown resting potential.
Data are reported as mean ± SEM unless otherwise stated. Differences
between control and toxin-treated channels were assessed using para-
metric statistical tests. 
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